New research shows that use of hydroxychloroquine did not predict prolonged QTc, a key measure of heart rate.
New research shows there is a need for aggressive preventive care to decrease racial health disparities and improve outcomes for lupus patients.
In a recent study, 86 percent of people with lupus and 72 percent of rheumatologists treating lupus agreed that having people fill out short surveys about fatigue, pain, and more helped improve communication.
For the most part, researchers found that people who ate healthy diets were no less likely to develop lupus than people who ate less nutritious diets — with one possible exception.
The findings highlight the importance of conversations between doctors and patients about drug costs.
This discrepancy is especially concerning given that Black and Hispanic women with lupus face a higher risk of pregnancy complications.
Lupus, an autoimmune disease, can be notoriously tricky to diagnose, yet it’s so important to catch it and treat it to help prevent long-term damage to your body.
The difference may be patients’ prolonged exposure to anti-malarial drugs, new research suggests.
Prescribing higher doses of HCQ and adjusting the amount to reach a specific blood level target could help lupus patients avoid blood clots and related complications.
Because of nationwide shortages of hydroxychloroquine (Plaquenil), rheumatology patients are suffering — and some are even scared for their lives.